2024-02-21 07:33:20 ET
- Repligen press release ( NASDAQ: RGEN ): Q4 Non-GAAP EPS of $0.33 misses by $0.01 .
- Revenue of $155.7M (-16.6% Y/Y) misses by $0.61M .
- Our cash, cash equivalents and short-term investments at December 31, 2023, were $751.3 million, compared to $623.8 million at December 31, 2022.
- FINANCIAL GUIDANCE FOR FISCAL YEAR 2024
CURRENT GUIDANCE(at February 21, 2024) | ||
FY 2024 | GAAP | Adjusted (non-GAAP) |
Total Reported Revenue | $620M - $650M vs. $660.68Mconsensus | $620M - $650M |
Year-over-Year Change | (3%) - 2% | (3%) - 2% |
Base Revenue Growth | - | (1%) - 4% |
Gross Margin | 49% - 50% | 49% - 50% |
Income from Operations | $33M - $38M | $83M - $88M |
Operating Margin | 5% - 6% | 13% - 14% |
Other Income (Expense) | $2M - $3M | $18M - $19M |
Adjusted EBITDA Margin | - | 18% - 19% |
Tax Rate on Pre-Tax Income | 26% | 21% |
Net Income | $26M - $30M | $80M - $84M |
Earnings Per Share - Diluted | $0.46 - $0.53 | $1.42 - $1.49 vs. $1.77 consensus |
Read the full article on Seeking Alpha
For further details see:
Repligen misses top-line and bottom-line estimates; initiates FY24 outlook